Thai PBS Thai PBS
Rising concerns over botulinum toxin resistance highlighted at ASCEND panel

Rising concerns over botulinum toxin resistance highlighted at ASCEND panel

12 Sept 03:46 Key points summarised by AI
  • An ASCEND panel highlighted rising concerns over botulinum toxin immunoresistance, with 81% of surveyed consumers reporting declining treatment efficacy, a significant increase from previous years.
  • Patient behaviors, including increasing dosages, shortening treatment intervals, and 'clinic-hopping' for more frequent injections, are identified as key factors exacerbating the development of resistance.
  • Experts emphasized the critical role of toxin purity in mitigating immunogenicity, advocating for the use of pure botulinum toxin formulations and adherence to minimum effective doses.
  • The ASCEND consensus paper recommends promoting pure formulations, implementing screening and management protocols for declining efficacy, and ensuring transparent patient education about immunoresistance.
  • Prevention is paramount, as starting with or switching to a pure toxin early can avert long-term complications, given that developed resistance can be prolonged or potentially irreversible.
Read full article
Health 1/1
Skip > Skip >